Related Experiment Video
Updated: Mar 20, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Pulmonary Disease Caused by Non-Tuberculous Mycobacteria
Nasstasja Wassilew1, Harald Hoffmann, Claire Andrejak
1Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
Non-tuberculous mycobacteria (NTM) cause lung disease, with rising cases in Europe. Understanding NTM epidemiology and improving diagnosis are crucial for better patient management and treatment outcomes.
Area of Science:
- Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Non-tuberculous mycobacteria (NTM) are environmental bacteria causing human disease, primarily chronic pulmonary infections.
- NTM pulmonary disease incidence is increasing globally, particularly in Europe, affecting individuals with and without underlying lung conditions.
- Current understanding of host and pathogen factors, diagnostic challenges, and treatment efficacy for NTM pulmonary disease remains limited.
Purpose of the Study:
- To describe the epidemiology, emerging pathogens, and geographical distribution of NTM pulmonary disease in non-cystic fibrosis patients in Europe.
- To review recent diagnostic innovations and current treatment recommendations for NTM pulmonary disease.
- To identify future research priorities for improving the management of NTM pulmonary disease.
Main Methods:
- Epidemiological review of NTM pulmonary disease in Europe.
- Analysis of emerging NTM pathogens and their geographical spread.
- Synthesis of recent advancements in diagnostic techniques and treatment strategies.
Main Results:
- NTM isolation and pulmonary disease are increasing in Europe.
- Specific NTM pathogens and their distribution patterns are identified.
- Challenges in differentiating contamination from infection/disease persist.
Conclusions:
- Improved diagnostics and a better understanding of NTM epidemiology are essential for effective management.
- Further research is needed to address treatment limitations and develop preventive strategies for NTM pulmonary disease.
- Targeted research priorities are identified to advance patient care for NTM pulmonary disease.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Other Pulmonary Disorders
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Atypical Pneumonia
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

